Tumor Blood Flow with Human Epidermal Growth Factor Receptor 2 Status and Clinicopathologic Findings--Preliminary Results

econvolution-based Dynamic Contrast-enhanced MR Imaging of Breast Tumors: Correlation of Tumor Blood Flow with Human Epidermal Growth Factor Receptor 2 Status and Clinicopathologic Findings--Preliminary Results
Smitha Makkat, Robert Luypaert, Tadeusz Stadnik, Claire Bourgain, Steven Sourbron, Martine Dujardin, Jacques De Greve, and Johan De Mey
Radiology 2008;249 471-482

Link to Journal

To our knowledge, we are the first to examine the association of model-independent MR-derived tumor blood flow, which is a simple and physiologically straightforward parameter, with clinicopathologic characteristics of prognosis, including human epidermal growth factor receptor 2 status